To our knowledge, this is the first study to reveal that S1PR1 reduces ceramide levels by controlling CerS6 translocation into the nucleus of ECs and then regulates CerS3 expression at the transcriptional level to induce angiogenesis and HCC progression (Fig. 9). This evidence concerns the gene CERS6 and hepatocellular carcinoma.